Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease

Angiology

Volumn 48, Issue 12, 1997, Pages 1063-1068

  Golden, Michael A ^a,b   Vaughn, David J ^a,b   Crooks, Gary W ^a,b   Holland, George A ^a,b   Bavaria, Joseph E ^a,b  

^a Hosp of the Univ of Pennsylvania ^*

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AORTA DISSECTION; ARTICLE; BLOOD VESSEL INJURY; CANCER CHEMOTHERAPY; CASE REPORT; CELL DAMAGE; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIUM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0030660506     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704801207     Document Type: Article

References (5)

1. Doll DC, Yarbro JW: Vascular toxicity associated with antineoplastic agents. Semin Oncol 19:580-596, 1992.
2. Ergin MA, Griepp RB: Dissections of the aorta. In: Glenn's Thoracic and Cardiovascular Surgery, ed. 6, ed. by Baue AE. Stamford, CT: Appleton & Lange, 1996, pp 2273-2298.
3. Lazo JS: Endothelial injury caused by antineoplastic agents. Biochem Pharmacol 35:1919-1923, 1986.
4. Adamson IYR, Bowden DH: The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77:185-190, 1974.
5. Nicholson GL, Custead SE: Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res 45:331-334, 1985.